ArticleFrontiers in medicine2026

Efficacy and safety of tenofovir alafenamide in HBeAg-positive and negative chronic hepatitis B patients aged over 30 years with normal ALT and detectable HBV DNA: a 96-week retrospective two-center study.

Yanfang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.